WallStreetZenWallStreetZen

NASDAQ: IPHA
Innate Pharma Sa Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innate Pharma Sa earnings were -$54.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest IPHA earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IPHA reported annual earnings of -$51.5M, with 512.7% growth. The next IPHA earnings date is Nov 13, 2025.

IPHA earnings history

Current Revenue
$14.9M
Current Earnings
-$54.2M
Current Profit Margin
-364.4%

IPHA Return on Equity

Current Company
-271.4%
Current Industry
-10.1%
Current Market
30.7%
IPHA's Return on Equity (-271.4%)... subscribe to Premium to read more.
High Return on Equity Performance

IPHA undefined

Current Company
-37.7%
Current Industry
-0.2%
IPHA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IPHA announces earnings.

IPHA undefined

Current Company
-65.09%
Current Industry
6.4%
IPHA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IPHA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IPHA-$46.80M-$54.18MN/A-$0.65
SLS-$25.68M-$26.26MN/A-$0.32
CBIO-$40.02M-$41.18MN/A-$34.93
BDTX$5.44M$5.09MN/A$0.08
MDWD-$18.14M-$28.23MN/A-$2.59
View Top Biotech Stocks

IPHA earnings dates

Next earnings date
Nov 13, 2025

Innate Pharma Sa Earnings Reports & History FAQ

What were Innate Pharma Sa's earnings last quarter?

On IPHA's earnings call on Invalid Date, Innate Pharma Sa (NASDAQ: IPHA) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total IPHA earnings for the quarter were N/A. In the same quarter last year, Innate Pharma Sa's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.

When does Innate Pharma Sa report earnings?

The next IPHA earnings call is Invalid Date. Add IPHA to your watchlist to be reminded of Innate Pharma Sa's next earnings date.

Is Innate Pharma Sa profitable or losing money?

As of the last Innate Pharma Sa earnings report, Innate Pharma Sa is currently losing money. Innate Pharma Sa's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$54.18 million, a 47.97% increase year over year.

What was IPHA's earnings growth in the past year?

As of Innate Pharma Sa's earnings date in Invalid Date, Innate Pharma Sa's earnings has grown year over year. IPHA earnings in the past year totalled -$54.18 million.

What are Innate Pharma Sa's earnings expectations?

The current EPS estimate for Innate Pharma Sa's earnings report in Invalid Date is $0.00.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.